Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.96%236.39B | 9.29%1.1T | 7.81%343.55B | 9.99%267.97B | 5.90%257.54B | 14.81%234.15B | 10.90%1.01T | 9.79%318.67B | 9.60%243.64B | 17.08%243.2B |
Cost of revenue | -1.38%170.69B | 9.20%799.93B | 8.55%241.72B | 8.69%195.32B | 5.38%189.81B | 15.36%173.07B | 11.36%732.53B | 11.34%222.68B | 10.92%179.71B | 17.32%180.11B |
Gross profit | 7.57%65.7B | 9.52%303.29B | 6.08%101.83B | 13.64%72.65B | 7.37%67.73B | 13.29%61.08B | 9.70%276.92B | 6.37%95.99B | 6.05%63.93B | 16.39%63.08B |
Operating expense | 4.38%48.45B | 4.89%197.22B | 7.82%53.42B | 3.68%49.99B | 2.52%47.4B | 5.39%46.41B | 5.88%188.04B | 3.06%49.55B | 9.79%48.21B | 7.02%46.24B |
Operating profit | 17.66%17.25B | 19.33%106.07B | 4.23%48.41B | 44.20%22.66B | 20.68%20.33B | 48.54%14.66B | 18.77%88.88B | 10.13%46.45B | -3.99%15.72B | 53.25%16.85B |
Net non-operating interest income (expenses) | -110.17%-620M | -17.67%-1.5B | -15.82%-476M | -31.41%-364M | -24.74%-363M | -0.34%-295M | -15.10%-1.27B | -23.42%-411M | -2.97%-277M | -3.93%-291M |
Non-operating interest income | -16.97%137M | -16.25%603M | -29.63%133M | -22.39%156M | -17.68%149M | 10.74%165M | 12.85%720M | 2.72%189M | 22.56%201M | 20.67%181M |
Non-operating interest expense | 64.57%757M | 5.42%2.1B | 1.50%609M | 8.79%520M | 8.47%512M | 3.84%460M | 14.28%1.99B | 16.05%600M | 10.39%478M | 9.77%472M |
Net investment income | -20.98%2.11B | 175.40%5.16B | 668.06%2.77B | 73.19%-600M | -44.76%327M | -15.54%2.67B | -46.97%1.87B | -69.75%360M | -360.54%-2.24B | 143.62%592M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -94.63%247M | -23.00%6.68B | 209.75%731M | -53.91%1.15B | -89.57%199M | 14.06%4.6B | -14.22%8.68B | -86.50%236M | 893.65%2.5B | -67.63%1.91B |
Income from associates and other participating interests | 0.85%-348M | 22.55%1.08B | -3.50%1.27B | 498.08%311M | 16.48%-152M | -14.71%-351M | -46.69%878M | -39.45%1.31B | -70.11%52M | 42.41%-182M |
Special income (charges) | 130.00%3M | 28.11%-872M | 18.16%-883M | -179.75%-63M | 123.46%84M | -106.90%-10M | 2.10%-1.21B | -908.41%-1.08B | -88.52%79M | 79.58%-358M |
Less:Other special charges | -130.00%-3M | -36.24%475M | -43.29%486M | 119.38%63M | -123.46%-84M | 106.90%10M | -19.81%745M | 522.17%857M | 52.76%-325M | -79.58%358M |
Less:Write off | ---- | -15.17%397M | 78.83%397M | ---- | ---- | ---- | 50.97%468M | -28.39%222M | ---- | ---- |
Other non-operating income (expenses) | 90.87%-143M | -24.38%-2.59B | 44.11%-389M | 101.27%11M | -67.01%-643M | -1,068.66%-1.57B | -399.28%-2.08B | -346.81%-696M | -991.75%-865M | -211.59%-385M |
Income before tax | -6.14%18.5B | 19.10%114.03B | 11.39%51.43B | 54.37%23.11B | 9.10%19.78B | 19.66%19.71B | 8.20%95.75B | -2.02%46.17B | -17.61%14.97B | 19.88%18.13B |
Income tax | -7.25%5.88B | 17.89%31.96B | 1.32%10.9B | 68.45%8.44B | 3.85%6.29B | 19.78%6.33B | 13.29%27.11B | -3.89%10.76B | -12.17%5.01B | 20.47%6.06B |
Net income | -5.61%12.63B | 19.58%82.07B | 14.44%40.53B | 47.29%14.68B | 11.74%13.49B | 19.59%13.38B | 6.32%68.63B | -1.44%35.41B | -20.10%9.96B | 19.59%12.07B |
Net income continuous operations | -5.61%12.63B | 19.58%82.07B | 14.45%40.53B | 47.29%14.68B | 11.74%13.49B | 19.60%13.38B | 6.32%68.63B | -1.44%35.41B | -20.10%9.96B | 19.59%12.07B |
Noncontrolling interests | 7.18%1.15B | -7.80%6.72B | -19.64%2.43B | 39.84%1.76B | -16.93%1.45B | -14.37%1.07B | 23.60%7.29B | 13.47%3.02B | 19.77%1.26B | 60.37%1.75B |
Net income attributable to the company | -6.73%11.48B | 22.83%75.35B | 17.63%38.1B | 48.38%12.91B | 16.59%12.04B | 23.88%12.3B | 4.58%61.35B | -2.63%32.39B | -23.78%8.7B | 14.67%10.33B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -6.73%11.48B | 22.83%75.35B | 17.63%38.1B | 48.38%12.91B | 16.59%12.04B | 23.88%12.3B | 4.58%61.35B | -2.63%32.39B | -23.78%8.7B | 14.67%10.33B |
Gross dividend payment | ||||||||||
Basic earnings per share | -6.73%80.34 | 22.83%527.57 | 17.63%266.73 | 48.41%90.41 | 16.58%84.29 | 23.89%86.14 | 4.58%429.5 | -2.63%226.75 | -23.78%60.92 | 14.67%72.3 |
Diluted earnings per share | -6.73%80.34 | 22.83%527.57 | 17.63%266.73 | 48.39%90.4004 | 16.58%84.29 | 23.89%86.14 | 4.58%429.5 | -2.63%226.75 | -23.78%60.92 | 14.67%72.2997 |
Dividend per share | 0 | 17.39%135 | 25.00%75 | 0 | 9.09%60 | 0 | 15.00%115 | 9.09%60 | 0 | 22.22%55 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |